Large-scale testing (Phase 3)Ended earlyNCT05074433
What this trial is testing
Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults
Who this might be right for
Immunocompromised
Regeneron Pharmaceuticals 66